Alkermes (ALKS) Amortization - Intangibles (2011 - 2026)
Alkermes' (ALKS) quarterly Amortization - Intangibles came in at $11.7 million in Q1 2026, up 11575.0% on a QoQ basis from $100000.0 in Q4 2025.
Alkermes (ALKS) Amortization - Intangibles (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Amortization - Intangibles data on file, last reported at $11.7 million in Q1 2026.
- On a quarterly basis, Amortization - Intangibles changed N/A year-over-year to $11.7 million in Q1 2026; TTM through Mar 2026 was $11.8 million, a 28619.51% increase from a year earlier, with the FY2025 full-year figure at $100000.0, down 90.91% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $11.7 million, up from $100000.0 in the prior quarter.
- Over the last five years, Amortization - Intangibles for ALKS reached as high as $11.7 million in Q1 2026 and fell as low as $13000.0 in Q4 2024.
- Historically, Amortization - Intangibles has averaged $6.1 million across 5 years, with a median of $8.9 million in 2022.
- Across the five-year window, Amortization - Intangibles tumbled 99.86% in 2024 and surged 669.23% in 2025, its largest moves.
- Year by year, Amortization - Intangibles stood at $9.2 million in 2022, then fell by 1.72% to $9.0 million in 2023, then tumbled by 99.86% to $13000.0 in 2024, then jumped by 669.23% to $100000.0 in 2025, then soared by 11575.0% to $11.7 million in 2026.
- Per Business Quant data, the three most recent Amortization - Intangibles figures were $11.7 million in Q1 2026, $100000.0 in Q4 2025, and $13000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Alkermes | 8.78 Bn | 8.27 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 8.80 Mn |
| Dec 31, 2022 | 9.17 Mn |
| Sep 30, 2022 | 9.17 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 8.97 Mn |
| Dec 31, 2021 | 9.62 Mn |
| Sep 30, 2021 | 9.62 Mn |
| Jun 30, 2021 | 9.51 Mn |
| Mar 31, 2021 | 9.41 Mn |
| Dec 31, 2020 | 9.97 Mn |
| Sep 30, 2020 | 9.92 Mn |